Monoclonal gammopathies of undetermined significance and smoldering multiple myeloma

John A. Lust, Diane F. Jelinek, Kathleen A. Donovan

Research output: Chapter in Book/Report/Conference proceedingChapter


Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic, premalignant clonal plasma cell proliferative disorder [1–4]. It was initially referred to as essential hyperglobulinemia by Jan Waldenström, as well as several other terms such as benign, idiopathic, asymptomatic, nonmyelomatous, discrete, cryptogenic, and rudimentary monoclonal gammopathy; dysimmunoglobulinemia; lanthanic monoclonal gammopathy; idiopathic paraproteinemia; and asymptomatic paraimmunoglobulinemia [5, 6]. However, since there is an indefinite risk of progression to multiple myeloma (MM) or related disorder such as macroglobulinemia (WM) or amyloidosis (AL), the term MGUS is now the accepted nomenclature [1, 2, 7, 8]. Smoldering multiple myeloma (SMM) is a clinically defined premalignant stage between MGUS and MM [9, 10]. MGUS and SMM must be differentiated from MM, and from a number of related plasma cell disorders using the criteria listed in see Table 1.2 in Chap. 1 [8, 11].

Original languageEnglish (US)
Title of host publicationMultiple Myeloma
Subtitle of host publicationDiagnosis and Treatment
PublisherSpringer New York
Number of pages16
ISBN (Electronic)9781461485209
ISBN (Print)9781461485193
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Monoclonal gammopathies of undetermined significance and smoldering multiple myeloma'. Together they form a unique fingerprint.

Cite this